This HTML5 document contains 144 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q44591895
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в жовтні 2008 vetenskaplig artikel 2008年学术文章 teaduslik artikkel artikel ilmiah videnskabelig artikel article scientifique научна статия artikulong pang-agham অক্টোবর ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ tudományos cikk scientific article published in October 2008 artículu científicu 2008年學術文章 2008年の論文 2008年學術文章 2008年学术文章 2008年学术文章 wissenschaftlicher Artikel artigo científico articolo scientifico vedecký článok επιστημονικό άρθρο artykuł naukowy scienca artikolo artikull shkencor 2008年學術文章 2008 nî lūn-bûn 2008年学术文章 naučni članak tieteellinen artikkeli scientific article published in October 2008 artigo científico artículo científico publicado en 2008 مقالة علمية نشرت في أكتوبر 2008 научни чланак scientific article published in October 2008 vědecký článek 2008年學術文章 2008年学术文章 2008년 논문 artigo científico vitskapeleg artikkel 2008年学术文章 научни чланак article scientific wetenschappelijk artikel научная статья bilimsel makale บทความทางวิทยาศาสตร์ bài báo khoa học מאמר מדעי სამეცნიერო სტატია 2008年學術文章 мақолаи илмӣ articol științific vitenskapelig artikkel գիտական հոդված հրատարակված 2008 թվականի հոկտեմբերին article científic
p:P577
wds:Q44591895-CBC7E302-CBAB-4540-BFEB-44B8A10D2CD5
wdt:P577
2008-10-01T00:00:00Z
p:P2860
wds:Q44591895-DBC71118-4FAA-4554-81B4-E545B10D9F46 wds:Q44591895-B607913F-A18D-4FD2-B1DA-23AFF9E0849E wds:Q44591895-85D10BAB-83B9-42BD-9D36-D1BE5A004A8E wds:Q44591895-8F1912C4-43F4-4053-AE07-2AD8386897A4 wds:Q44591895-EAEFEB15-31F9-4D1B-B24B-3CC9B274DAD5 wds:Q44591895-EFBE518D-65B9-44B6-A149-DB5034F08FEF wds:Q44591895-F9AC4EE9-C5C4-4FC0-AB17-633AD318A2CF wds:Q44591895-56C4F70D-6024-4E07-8D29-FF9613258231 wds:Q44591895-2F95DC37-AB3A-4CEE-B8E7-EFF8298C82A5 wds:Q44591895-25813F2C-FAB6-4213-B925-BB09DE62E89A wds:Q44591895-2896EC34-B28F-4393-B483-6C0BDA0D1BAA wds:Q44591895-1395375D-5BA0-4796-94B6-3F3744313962
wdt:P2860
wd:Q28191546 wd:Q44422799 wd:Q43050712 wd:Q33243658 wd:Q46525959 wd:Q28285876 wd:Q46588962 wd:Q58204891 wd:Q45171484 wd:Q56461993 wd:Q28202504 wd:Q34189548
p:P2093
wds:Q44591895-2EF5B1E3-D364-4BAE-8565-B5E8A3F0A532 wds:Q44591895-57579F99-2A06-4C3F-9C8E-42D393E785AE wds:Q44591895-4C30509F-2E48-419A-AD7A-3DC1EB6F6BD6 wds:Q44591895-13078AD9-32C5-406E-966B-716AF393203E wds:Q44591895-2813E86D-65DC-4252-A609-D5940E8D533F wds:Q44591895-21AEBA1B-9167-48E0-B6FD-E79DE17D671E wds:Q44591895-101774EA-5A4F-4CDE-AC19-B87CB5CE5046 wds:Q44591895-B1C9BB26-491A-4480-88E3-7808C12F866B wds:Q44591895-D3E87157-B92C-44DA-A9B3-2E4CAABF00BF wds:Q44591895-78CD8164-F198-4BC7-BE1D-E7BD38F0BD2B wds:Q44591895-AA9036AF-3930-47B2-900B-B0F7DE38CC28
wdt:P2093
Eduard Cabré Eugeni Domènech Antonio López San Román Cristina Saro Yamile Zabana Miquel A Gassull Joaquín Hinojosa Daniel Ginard Robert Araméndiz Míriam Mañosa José Luis Cabriada
rdfs:label
Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy
skos:prefLabel
Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy
schema:name
Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy
p:P50
wds:Q44591895-97F65E87-EE63-478B-BB0B-831EA5427D16 wds:Q44591895-67E037D0-6CD1-4746-85FE-36704B421E4F
wdt:P50
wd:Q37829251 wd:Q57943460
p:P1476
wds:Q44591895-43BEB341-5640-4328-B422-CCCBA7890FFA
wdt:P1476
Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy
p:P304
wds:Q44591895-CF7216C7-39F2-45EF-9D43-725D323C60DA
wdt:P304
1387-1391
p:P31
wds:Q44591895-12086548-3F6E-4390-89DD-495BEBE07554
wdt:P31
wd:Q13442814
p:P921
wds:Q44591895-43EE180A-FB47-493D-A8D2-56BC680312B7 wds:Q44591895-9F44D990-D965-4300-BE55-B7978D410276 wds:Q44591895-B4CAD7AE-6971-4F42-84EF-412FDE1BFE96
wdt:P921
wd:Q18032037 wd:Q917447 wd:Q1536078
p:P698
wds:Q44591895-BE53D8EB-5444-4BC6-A6F8-639D44B2EBCD
wdtn:P698
n8:18452206
wdt:P698
18452206
p:P1433
wds:Q44591895-15001C25-4AE0-4410-8820-86D98B460B84
wdt:P1433
wd:Q15749161
p:P433
wds:Q44591895-842E11BB-6651-4512-A74B-AD5A507C2C7C
p:P478
wds:Q44591895-E143CB29-2C16-44E2-A65A-9F12CC01AE4D
wdt:P433
10
wdt:P478
14
p:P356
wds:Q44591895-AC6F620C-983B-4AF8-94F7-7E015521BA95
wdtn:P356
n12:IBD.20496
wdt:P356
10.1002/IBD.20496
p:P5875
wds:Q44591895-14E6C5AF-A447-42BF-ABF0-52558C4FC70B
wdt:P5875
5400932